-
Large-scale machine learning-based phenoty** significantly improves genomic discovery for optic nerve head morphology
Authors:
Babak Alipanahi,
Farhad Hormozdiari,
Babak Behsaz,
Justin Cosentino,
Zachary R. McCaw,
Emanuel Schorsch,
D. Sculley,
Elizabeth H. Dorfman,
Sonia Phene,
Naama Hammel,
Andrew Carroll,
Anthony P. Khawaja,
Cory Y. McLean
Abstract:
Genome-wide association studies (GWAS) require accurate cohort phenoty**, but expert labeling can be costly, time-intensive, and variable. Here we develop a machine learning (ML) model to predict glaucomatous optic nerve head features from color fundus photographs. We used the model to predict vertical cup-to-disc ratio (VCDR), a diagnostic parameter and cardinal endophenotype for glaucoma, in 6…
▽ More
Genome-wide association studies (GWAS) require accurate cohort phenoty**, but expert labeling can be costly, time-intensive, and variable. Here we develop a machine learning (ML) model to predict glaucomatous optic nerve head features from color fundus photographs. We used the model to predict vertical cup-to-disc ratio (VCDR), a diagnostic parameter and cardinal endophenotype for glaucoma, in 65,680 Europeans in the UK Biobank (UKB). A GWAS of ML-based VCDR identified 299 independent genome-wide significant (GWS; $P\leq5\times10^{-8}$) hits in 156 loci. The ML-based GWAS replicated 62 of 65 GWS loci from a recent VCDR GWAS in the UKB for which two ophthalmologists manually labeled images for 67,040 Europeans. The ML-based GWAS also identified 92 novel loci, significantly expanding our understanding of the genetic etiologies of glaucoma and VCDR. Pathway analyses support the biological significance of the novel hits to VCDR, with select loci near genes involved in neuronal and synaptic biology or known to cause severe Mendelian ophthalmic disease. Finally, the ML-based GWAS results significantly improve polygenic prediction of VCDR and primary open-angle glaucoma in the independent EPIC-Norfolk cohort.
△ Less
Submitted 25 November, 2020;
originally announced November 2020.
-
Improving Medical Annotation Quality to Decrease Labeling Burden Using Stratified Noisy Cross-Validation
Authors:
Joy Hsu,
Sonia Phene,
Akinori Mitani,
Jieying Luo,
Naama Hammel,
Jonathan Krause,
Rory Sayres
Abstract:
As machine learning has become increasingly applied to medical imaging data, noise in training labels has emerged as an important challenge. Variability in diagnosis of medical images is well established; in addition, variability in training and attention to task among medical labelers may exacerbate this issue. Methods for identifying and mitigating the impact of low quality labels have been stud…
▽ More
As machine learning has become increasingly applied to medical imaging data, noise in training labels has emerged as an important challenge. Variability in diagnosis of medical images is well established; in addition, variability in training and attention to task among medical labelers may exacerbate this issue. Methods for identifying and mitigating the impact of low quality labels have been studied, but are not well characterized in medical imaging tasks. For instance, Noisy Cross-Validation splits the training data into halves, and has been shown to identify low-quality labels in computer vision tasks; but it has not been applied to medical imaging tasks specifically. In this work we introduce Stratified Noisy Cross-Validation (SNCV), an extension of noisy cross validation. SNCV can provide estimates of confidence in model predictions by assigning a quality score to each example; stratify labels to handle class imbalance; and identify likely low-quality labels to analyze the causes. We assess performance of SNCV on diagnosis of glaucoma suspect risk from retinal fundus photographs, a clinically important yet nuanced labeling task. Using training data from a previously-published deep learning model, we compute a continuous quality score (QS) for each training example. We relabel 1,277 low-QS examples using a trained glaucoma specialist; the new labels agree with the SNCV prediction over the initial label >85% of the time, indicating that low-QS examples mostly reflect labeler errors. We then quantify the impact of training with only high-QS labels, showing that strong model performance may be obtained with many fewer examples. By applying the method to randomly sub-sampled training dataset, we show that our method can reduce labelling burden by approximately 50% while achieving model performance non-inferior to using the full dataset on multiple held-out test sets.
△ Less
Submitted 22 September, 2020;
originally announced September 2020.
-
Deep Learning and Glaucoma Specialists: The Relative Importance of Optic Disc Features to Predict Glaucoma Referral in Fundus Photos
Authors:
Sonia Phene,
R. Carter Dunn,
Naama Hammel,
Yun Liu,
Jonathan Krause,
Naho Kitade,
Mike Schaekermann,
Rory Sayres,
Derek J. Wu,
Ashish Bora,
Christopher Semturs,
Anita Misra,
Abigail E. Huang,
Arielle Spitze,
Felipe A. Medeiros,
April Y. Maa,
Monica Gandhi,
Greg S. Corrado,
Lily Peng,
Dale R. Webster
Abstract:
Glaucoma is the leading cause of preventable, irreversible blindness world-wide. The disease can remain asymptomatic until severe, and an estimated 50%-90% of people with glaucoma remain undiagnosed. Glaucoma screening is recommended for early detection and treatment. A cost-effective tool to detect glaucoma could expand screening access to a much larger patient population, but such a tool is curr…
▽ More
Glaucoma is the leading cause of preventable, irreversible blindness world-wide. The disease can remain asymptomatic until severe, and an estimated 50%-90% of people with glaucoma remain undiagnosed. Glaucoma screening is recommended for early detection and treatment. A cost-effective tool to detect glaucoma could expand screening access to a much larger patient population, but such a tool is currently unavailable. We trained a deep learning algorithm using a retrospective dataset of 86,618 images, assessed for glaucomatous optic nerve head features and referable glaucomatous optic neuropathy (GON). The algorithm was validated using 3 datasets. For referable GON, the algorithm had an AUC of 0.945 (95% CI, 0.929-0.960) in dataset A (1205 images, 1 image/patient; 18.1% referable), images adjudicated by panels of Glaucoma Specialists (GSs); 0.855 (95% CI, 0.841-0.870) in dataset B (9642 images, 1 image/patient; 9.2% referable), images from Atlanta Veterans Affairs Eye Clinic diabetic teleretinal screening program; and 0.881 (95% CI, 0.838-0.918) in dataset C (346 images, 1 image/patient; 81.7% referable), images from Dr. Shroff's Charity Eye Hospital's glaucoma clinic. The algorithm showed significantly higher sensitivity than 7 of 10 graders not involved in determining the reference standard, including 2 of 3 GSs, and showed higher specificity than 3 graders, while remaining comparable to others. For both GSs and the algorithm, the most crucial features related to referable GON were: presence of vertical cup-to-disc ratio of 0.7 or more, neuroretinal rim notching, retinal nerve fiber layer defect, and bared circumlinear vessels. An algorithm trained on fundus images alone can detect referable GON with higher sensitivity than and comparable specificity to eye care providers. The algorithm maintained good performance on an independent dataset with diagnoses based on a full glaucoma workup.
△ Less
Submitted 30 August, 2019; v1 submitted 20 December, 2018;
originally announced December 2018.
-
Deep Learning vs. Human Graders for Classifying Severity Levels of Diabetic Retinopathy in a Real-World Nationwide Screening Program
Authors:
Paisan Raumviboonsuk,
Jonathan Krause,
Peranut Chotcomwongse,
Rory Sayres,
Rajiv Raman,
Kasumi Widner,
Bilson J L Campana,
Sonia Phene,
Kornwipa Hemarat,
Mongkol Tadarati,
Sukhum Silpa-Acha,
Jirawut Limwattanayingyong,
Chetan Rao,
Oscar Kuruvilla,
Jesse Jung,
Jeffrey Tan,
Surapong Orprayoon,
Chawawat Kangwanwongpaisan,
Ramase Sukulmalpaiboon,
Chainarong Luengchaichawang,
Jitumporn Fuangkaew,
Pipat Kongsap,
Lamyong Chualinpha,
Sarawuth Saree,
Srirat Kawinpanitan
, et al. (7 additional authors not shown)
Abstract:
Deep learning algorithms have been used to detect diabetic retinopathy (DR) with specialist-level accuracy. This study aims to validate one such algorithm on a large-scale clinical population, and compare the algorithm performance with that of human graders. 25,326 gradable retinal images of patients with diabetes from the community-based, nation-wide screening program of DR in Thailand were analy…
▽ More
Deep learning algorithms have been used to detect diabetic retinopathy (DR) with specialist-level accuracy. This study aims to validate one such algorithm on a large-scale clinical population, and compare the algorithm performance with that of human graders. 25,326 gradable retinal images of patients with diabetes from the community-based, nation-wide screening program of DR in Thailand were analyzed for DR severity and referable diabetic macular edema (DME). Grades adjudicated by a panel of international retinal specialists served as the reference standard. Across different severity levels of DR for determining referable disease, deep learning significantly reduced the false negative rate (by 23%) at the cost of slightly higher false positive rates (2%). Deep learning algorithms may serve as a valuable tool for DR screening.
△ Less
Submitted 18 October, 2018;
originally announced October 2018.